A novel tumor doubling time-related immune gene signature for prognosis prediction in hepatocellular carcinoma

Abstract

In summary, the prognostic signature based on TDTRGs and IRGs could effectively help clinicians classify HCC patients for prognosis prediction and individualized immunotherapies.